{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:59:35Z","timestamp":1772150375220,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sydney West Radiation Oncology Network Royal Australian and New Zealand College of Radiologists"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Treatment personalisation remains an unmet need in oropharynx cancer (OPC). We aimed to determine whether gene expression signatures improved upon clinico-pathological predictors of outcome in OPC. The clinico-pathological predictors, AJCC version 7 (AJCC 7), AJCC 8, and a clinical algorithm, were assessed in 4 public series of OPC (n\u2009=\u2009235). Literature review identified 16 mRNA gene expression signatures of radiosensitivity, HPV status, tumour hypoxia, and microsatellite instability. We quality tested signatures using a novel<jats:italic>sigQC<\/jats:italic>methodology, and added signatures to clinico-pathological variables as predictors of survival, in univariate and multivariate analyses. AJCC 7 Stage was not predictive of recurrence-free survival (RFS) or overall survival (OS). AJCC 8 significantly predicted RFS and OS. Gene signature quality was highly variable. Among HPV-positive cases, signatures for radiosensitivity, hypoxia, and microsatellite instability revealed significant underlying inter-tumour biological heterogeneity, but did not show prognostic significance when adjusted for clinical covariates. Surprisingly, among HPV-negative cases, a gene signature for HPV status was predictive of survival, even after adjustment for clinical covariates. Across the whole series, several gene signatures representing HPV and microsatellite instability remained significant in multivariate analysis. However, quality control and independent validation remain to be performed to add prognostic information above recently improved clinico-pathological variables.<\/jats:p>","DOI":"10.1038\/s41598-020-66983-x","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T10:02:51Z","timestamp":1592906571000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Role of gene signatures combined with pathology in classification of oropharynx head and neck cancer"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5027-1277","authenticated-orcid":false,"given":"Andrew","family":"Dhawan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2971-7673","authenticated-orcid":false,"given":"Jacob","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purnima","family":"Sundaresan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Veness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Porceddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Hau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-8409","authenticated-orcid":false,"given":"Adrian L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca M.","family":"Buffa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harriet E.","family":"Gee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"66983_CR1","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1200\/JCO.2015.61.4115","volume":"33","author":"J Ringash","year":"2015","unstructured":"Ringash, J. Survivorship and Quality of Life in Head and Neck Cancer. J. Clin. Oncol. 33, 3322\u20133327 (2015).","journal-title":"J. Clin. Oncol."},{"key":"66983_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/hed.23942","volume":"38","author":"A Hong","year":"2016","unstructured":"Hong, A. et al. Rising prevalence of human papillomavirus-related oropharyngeal cancer in Australia over the last 2 decades. Head Neck 38, 743\u2013750 (2016).","journal-title":"Head Neck"},{"key":"66983_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.oraloncology.2013.12.019","volume":"50","author":"KB Pytynia","year":"2014","unstructured":"Pytynia, K. B., Dahlstrom, K. R. & Sturgis, E. M. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol. 50, 380\u2013386 (2014).","journal-title":"Oral Oncol."},{"key":"66983_CR4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1200\/JCO.2007.14.1713","volume":"26","author":"AK Chaturvedi","year":"2008","unstructured":"Chaturvedi, A. K., Engels, E. A., Anderson, W. F. & Gillison, M. L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J. Clin. Oncol. 26, 612\u2013619 (2008).","journal-title":"J. Clin. Oncol."},{"key":"66983_CR5","doi-asserted-by":"crossref","unstructured":"Erratum to Ringash, J. et al. Effect of p16 status on the quality-of-life experience during chemoradiation for locally advanced oropharyngeal cancer: a substudy of randomized trial trans-Tasman radiation oncology group (TROG) 02.02 (HeadSTART). Int J Radiat Oncol Biol Phys 2017;97, 678\u2013686. Int. J. Radiat. Oncol. Biol. Phys. 99, 244 (2017).","DOI":"10.1016\/j.ijrobp.2017.05.042"},{"key":"66983_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/coa.12674","volume":"42","author":"T Bird","year":"2017","unstructured":"Bird, T. et al. Outcomes of intensity-modulated radiotherapy as primary treatment for oropharyngeal squamous cell carcinoma - a European singleinstitution analysis. Clin Otolaryngol 42, 115\u2013122 (2017).","journal-title":"Clin Otolaryngol"},{"key":"66983_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.oraloncology.2017.12.011","volume":"77","author":"M Huo","year":"2018","unstructured":"Huo, M., Panizza, B., Bernard, A. & Porceddu, S. V. Head and neck squamous cell carcinoma of unknown primary: Outcomes of a pre-defined institutional treatment policy in a region with a high prevalence of skin cancer. Oral Oncol. 77, 43\u201348 (2018).","journal-title":"Oral Oncol."},{"key":"66983_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang, K. K. et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 363, 24\u201335 (2010).","journal-title":"N. Engl. J. Med."},{"key":"66983_CR9","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1158\/0008-5472.CAN-13-0587","volume":"73","author":"RJ Kimple","year":"2013","unstructured":"Kimple, R. J. et al. Enhanced radiation sensitivity in HPV-positive head and neck cancer. Cancer Res. 73, 4791\u20134800 (2013).","journal-title":"Cancer Res."},{"key":"66983_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.radonc.2014.08.026","volume":"113","author":"JW Park","year":"2014","unstructured":"Park, J. W. et al. Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage. Radiother Oncol 113, 337\u2013344 (2014).","journal-title":"Radiother Oncol"},{"key":"66983_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.radonc.2013.03.013","volume":"107","author":"T Rieckmann","year":"2013","unstructured":"Rieckmann, T. et al. HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity. Radiother Oncol 107, 242\u2013246 (2013).","journal-title":"Radiother Oncol"},{"key":"66983_CR12","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/carcin\/bgv126","volume":"36","author":"R Marullo","year":"2015","unstructured":"Marullo, R. et al. HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells. Carcinogenesis 36, 1397\u20131406 (2015).","journal-title":"Carcinogenesis"},{"key":"66983_CR13","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/ijc.28847","volume":"136","author":"H Mirghani","year":"2015","unstructured":"Mirghani, H. et al. Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives. Int. J. Cancer 136, 1494\u20131503 (2015).","journal-title":"Int. J. Cancer"},{"key":"66983_CR14","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.ijrobp.2017.03.021","volume":"98","author":"PM Harari","year":"2017","unstructured":"Harari, P. M. Why So Challenging to Personalize Radiation Dose? Int. J. Radiat. Oncol. Biol. Phys. 98, 1012\u20131013 (2017).","journal-title":"J. Radiat. Oncol. Biol. Phys."},{"key":"66983_CR15","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1158\/1078-0432.CCR-14-2898","volume":"21","author":"C Speers","year":"2015","unstructured":"Speers, C. et al. Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer. Clin. Cancer Res. 21, 3667\u20133677 (2015).","journal-title":"Clin. Cancer Res."},{"key":"66983_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0360-3016(99)00158-3","volume":"45","author":"PH Elkhuizen","year":"1999","unstructured":"Elkhuizen, P. H. et al. Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression. Int. J. Radiat. Oncol. Biol. Phys. 45, 73\u201383 (1999).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"66983_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijrobp.2013.05.052","volume":"87","author":"F Hafeez","year":"2013","unstructured":"Hafeez, F. et al. Is Ki-67 expression prognostic for local relapse in early-stage breast cancer patients treated with breast conservation therapy (BCT)? Int. J. Radiat. Oncol. Biol. Phys. 87, 344\u2013348 (2013).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"66983_CR18","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.ijrobp.2015.08.046","volume":"93","author":"HE Gee","year":"2015","unstructured":"Gee, H. E. et al. MicroRNA-Related DNA Repair\/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast Cancer. Int. J. Radiat. Oncol. Biol. Phys. 93, 1104\u20131114 (2015).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"66983_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3322\/caac.21389","volume":"67","author":"WM Lydiatt","year":"2017","unstructured":"Lydiatt, W. M. et al. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J. Clin. 67, 122\u2013137 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"66983_CR20","doi-asserted-by":"crossref","unstructured":"Brierley, J. D., Gospodarowicz, M. K. & Wittekind, C. TNM Classification of Malignant Tumours. (John Wiley & Sons, 2017).","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"66983_CR21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1470-2045(17)30246-2","volume":"18","author":"AM Chen","year":"2017","unstructured":"Chen, A. M. et al. Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study. Lancet Oncol. 18, 803\u2013811 (2017).","journal-title":"Lancet Oncol."},{"key":"66983_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","volume":"18","author":"JG Scott","year":"2017","unstructured":"Scott, J. G. et al. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study. Lancet Oncol. 18, 202\u2013211 (2017).","journal-title":"Lancet Oncol."},{"key":"66983_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1158\/0008-5472.CAN-07-2120","volume":"68","author":"SA Amundson","year":"2008","unstructured":"Amundson, S. A. et al. Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. Cancer Res. 68, 415\u2013424 (2008).","journal-title":"Cancer Res."},{"key":"66983_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-13-348","volume":"13","author":"HS Kim","year":"2012","unstructured":"Kim, H. S. et al. Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells. BMC Genomics 13, 348 (2012).","journal-title":"BMC Genomics"},{"key":"66983_CR25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/sj.bjc.6605450","volume":"102","author":"F Buffa","year":"2010","unstructured":"Buffa, F., Harris, A., West, C. & Miller, C. Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene. British Journal of Cancer 102, 428\u2013435 (2010).","journal-title":"British Journal of Cancer"},{"key":"66983_CR26","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1158\/1078-0432.CCR-13-0542","volume":"19","author":"A Eustace","year":"2013","unstructured":"Eustace, A. et al. A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer. Clin. Cancer Res. 19, 4879\u20134888 (2013).","journal-title":"Clin. Cancer Res."},{"key":"66983_CR27","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-11-1182","volume":"71","author":"K Toustrup","year":"2011","unstructured":"Toustrup, K. et al. Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer. Cancer Res. 71, 5923\u20135931 (2011).","journal-title":"Cancer Res."},{"key":"66983_CR28","doi-asserted-by":"publisher","first-page":"18490","DOI":"10.1073\/pnas.0809242105","volume":"105","author":"RR Weichselbaum","year":"2008","unstructured":"Weichselbaum, R. R. et al. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc. Natl. Acad. Sci. USA 105, 18490\u201318495 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66983_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc.2016.36","volume":"16","author":"SL Topalian","year":"2016","unstructured":"Topalian, S. L., Taube, J. M., Anders, R. A. & Pardoll, D. M. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat. Rev. Cancer 16, 275\u2013287 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"66983_CR30","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.otohns.2009.07.007","volume":"141","author":"C Zuo","year":"2009","unstructured":"Zuo, C. et al. Increased microsatellite instability and epigenetic inactivation of the hMLH1 gene in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 141, 484\u2013490 (2009).","journal-title":"Otolaryngol Head Neck Surg"},{"key":"66983_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/sj.onc.1209009","volume":"25","author":"K Koinuma","year":"2006","unstructured":"Koinuma, K. et al. Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Oncogene 25, 139\u2013146 (2006).","journal-title":"Oncogene"},{"key":"66983_CR32","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1200\/JCO.2011.38.6490","volume":"30","author":"T Watanabe","year":"2012","unstructured":"Watanabe, T. et al. Chromosomal instability (CIN) phenotype, CIN high or CIN low, predicts survival for colorectal cancer. J. Clin. Oncol. 30, 2256\u20132264 (2012).","journal-title":"J. Clin. Oncol."},{"key":"66983_CR33","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature06915","volume":"452","author":"LJ van\u2019t Veer","year":"2008","unstructured":"van\u2019t Veer, L. J. & Bernards, R. Enabling personalized cancer medicine through analysis of gene-expression patterns. Nature 452, 564\u2013570 (2008).","journal-title":"Nature"},{"key":"66983_CR34","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"Cancer Genome Atlas Network","year":"2015","unstructured":"Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 517, 576\u2013582 (2015).","journal-title":"Nature"},{"key":"66983_CR35","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1002\/ijc.29649","volume":"137","author":"G Wichmann","year":"2015","unstructured":"Wichmann, G. et al. The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer. Int. J. Cancer 137, 2846\u20132857 (2015).","journal-title":"Int. J. Cancer"},{"key":"66983_CR36","doi-asserted-by":"publisher","first-page":"e56823","DOI":"10.1371\/journal.pone.0056823","volume":"8","author":"V Walter","year":"2013","unstructured":"Walter, V. et al. Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes. PLoS ONE 8, e56823 (2013).","journal-title":"PLoS ONE"},{"key":"66983_CR37","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge, S. B. & Compton, C. C. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of Surgical Oncology 17, 1471\u20131474 (2010).","journal-title":"Annals of Surgical Oncology"},{"key":"66983_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).","journal-title":"BMC Bioinformatics"},{"key":"66983_CR39","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/cncr.25009","volume":"116","author":"HE Gee","year":"2010","unstructured":"Gee, H. E. et al. hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 116, 2148\u20132158 (2010).","journal-title":"Cancer"},{"key":"66983_CR40","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41596-019-0136-8","volume":"14","author":"A Dhawan","year":"2019","unstructured":"Dhawan, A. et al. Guidelines for using sigQC for systematic evaluation of gene signatures. Nat Protoc 14, 1377\u20131400 (2019).","journal-title":"Nat Protoc"},{"key":"66983_CR41","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1158\/0008-5472.CAN-06-3619","volume":"67","author":"D Pyeon","year":"2007","unstructured":"Pyeon, D. et al. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head\/neck and cervical cancers. Cancer Res. 67, 4605\u20134619 (2007).","journal-title":"Cancer Res."},{"key":"66983_CR42","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ijrobp.2019.06.2531","volume":"105","author":"E-L G\u00f6ttgens","year":"2019","unstructured":"G\u00f6ttgens, E.-L. et al. Inhibition of CDK4\/CDK6 Enhances Radiosensitivity of HPV Negative Head and Neck Squamous Cell Carcinomas. Int. J. Radiat. Oncol. Biol. Phys. 105, 548\u2013558 (2019).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"66983_CR43","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1200\/JCO.2010.29.2904","volume":"28","author":"D Rischin","year":"2010","unstructured":"Rischin, D. et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J. Clin. Oncol. 28, 4142\u20134148 (2010).","journal-title":"J. Clin. Oncol."},{"key":"66983_CR44","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","volume":"21","author":"TY Seiwert","year":"2015","unstructured":"Seiwert, T. Y. et al. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin. Cancer Res. 21, 632\u2013641 (2015).","journal-title":"Clin. Cancer Res."},{"key":"66983_CR45","doi-asserted-by":"crossref","unstructured":"Gleber-Netto, F. O. et al. Variations in HPV function are associated with survival in squamous cell carcinoma. JCI Insight 4, (2019).","DOI":"10.1172\/jci.insight.124762"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66983-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66983-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66983-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T06:17:14Z","timestamp":1723097834000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66983-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["66983"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-66983-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]},"assertion":[{"value":"14 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.G.S. has stock options in Cvergenx and a pending patent for radiation sensitivity index (RSI). All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10226"}}